Crazy how this is still trading below the proposed take-over price. In saying that, still undervalued the company so if management play their cards right, we may get a higher price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025